152 related articles for article (PubMed ID: 31917494)
1. Treatment of three hereditary leiomyomatosis patients with cryotherapy.
Uyar B; Acar EM; Subaşıoğlu A
Dermatol Ther; 2020 Mar; 33(2):e13226. PubMed ID: 31917494
[TBL] [Abstract][Full Text] [Related]
2. Hereditary leiomyomatosis and renal cell cancer syndrome: An update and review.
Patel VM; Handler MZ; Schwartz RA; Lambert WC
J Am Acad Dermatol; 2017 Jul; 77(1):149-158. PubMed ID: 28314682
[TBL] [Abstract][Full Text] [Related]
3. Hereditary Leiomyomatosis and Renal Cell Cancer (HLRCC): Report of a Family Pedigree.
Choi G; Kimonis V; Hall K; Lau WL
Am J Med Sci; 2020 Dec; 360(6):724-727. PubMed ID: 32703534
[TBL] [Abstract][Full Text] [Related]
4. [Hereditary leiomyomatosis and renal cell cancer - HLRCC/multiple cutaneous and uterine leimomyomatosis - MCUL].
Plevová P; Hladíková A; Tesařová M
Klin Onkol; 2012; 25 Suppl():S55-8. PubMed ID: 22920208
[TBL] [Abstract][Full Text] [Related]
5. A novel missense mutation in fumarate hydratase in an Italian patient with a diffuse variant of cutaneous leiomyomatosis (Reed's syndrome).
Rongioletti F; Fausti V; Ferrando B; Parodi A; Mandich P; Pasini B
Dermatology; 2010; 221(4):378-80. PubMed ID: 21051878
[TBL] [Abstract][Full Text] [Related]
6. Hereditary Leiomyomatosis and Renal Cell Cancer: Clinical, Molecular, and Screening Features in a Cohort of 185 Affected Individuals.
Forde C; Lim DHK; Alwan Y; Burghel G; Butland L; Cleaver R; Dixit A; Evans DG; Hanson H; Lalloo F; Oliveira P; Vialard L; Wallis Y; Maher ER; Woodward ER
Eur Urol Oncol; 2020 Dec; 3(6):764-772. PubMed ID: 31831373
[TBL] [Abstract][Full Text] [Related]
7. A retrospective review of 48 individuals, including 12 families, molecularly diagnosed with hereditary leiomyomatosis and renal cell cancer (HLRCC).
Bhola PT; Gilpin C; Smith A; Graham GE
Fam Cancer; 2018 Oct; 17(4):615-620. PubMed ID: 29423582
[TBL] [Abstract][Full Text] [Related]
8. Novel Fumarate Hydratase Mutation in Siblings With Early Onset Uterine Leiomyomas and Hereditary Leiomyomatosis and Renal Cell Cancer Syndrome.
Gunnala V; Pereira N; Irani M; Lilienthal D; Pirog EC; Soslow R; Caputo TA; Elias R; Kligman I; Rosenwaks Z
Int J Gynecol Pathol; 2018 May; 37(3):256-261. PubMed ID: 28700432
[TBL] [Abstract][Full Text] [Related]
9. Multiple cutaneous leiomyomas leading to discovery of novel splice mutation in the fumarate hydratase gene associated with HLRCC.
Tan RYP; Walsh M; Howard A; Winship I
Australas J Dermatol; 2017 Nov; 58(4):e246-e248. PubMed ID: 28266706
[TBL] [Abstract][Full Text] [Related]
10. [From gene to disease; cutaneous leiomyomatosis].
Badeloe S; van Geel M; van Steensel MA; Steijlen PM; Poblete-Gutiérrez P; Frank JA
Ned Tijdschr Geneeskd; 2007 Feb; 151(5):300-4. PubMed ID: 17326474
[TBL] [Abstract][Full Text] [Related]
11. Prospective Detection of Germline Mutation of Fumarate Hydratase in Women With Uterine Smooth Muscle Tumors Using Pathology-based Screening to Trigger Genetic Counseling for Hereditary Leiomyomatosis Renal Cell Carcinoma Syndrome: A 5-Year Single Institutional Experience.
Rabban JT; Chan E; Mak J; Zaloudek C; Garg K
Am J Surg Pathol; 2019 May; 43(5):639-655. PubMed ID: 30741757
[TBL] [Abstract][Full Text] [Related]
12. Case of hereditary leiomyomatosis and renal cell cancer showing multiple cutaneous leiomyomas harboring a recurrent nonsense mutation in the fumarate hydratase gene.
Mai S; Yanagi T; Shimano M; Nishie W; Arita K; Ujiie H
J Dermatol; 2022 Jan; 49(1):e42-e43. PubMed ID: 34755393
[No Abstract] [Full Text] [Related]
13. Renal cell carcinoma in young FH mutation carriers: case series and review of the literature.
Hol JA; Jongmans MCJ; Littooij AS; de Krijger RR; Kuiper RP; van Harssel JJT; Mensenkamp A; Simons M; Tytgat GAM; van den Heuvel-Eibrink MM; van Grotel M
Fam Cancer; 2020 Jan; 19(1):55-63. PubMed ID: 31792767
[TBL] [Abstract][Full Text] [Related]
14. First Presentation of Hereditary Leiomyomatosis and Renal Cell Cancer Syndrome in Pregnancy.
Woolner K; O'Toole A; LaBerge L
J Cutan Med Surg; 2016 Jul; 20(4):334-6. PubMed ID: 26902252
[TBL] [Abstract][Full Text] [Related]
15. Hereditary leiomyomatosis and renal cell carcinoma syndrome: a case report and implications of early onset.
Çaliskan E; Bodur S; Ulubay M; Özmen I; Çiçek AF; Deveci G; Kaya E
An Bras Dermatol; 2017; 92(5 Suppl 1):88-91. PubMed ID: 29267457
[TBL] [Abstract][Full Text] [Related]
16. Hereditary leiomyomatosis and renal cell cancer syndrome: a family affair.
Teh J; Kinnear N; Douglass-Molloy H; Hennessey DB
BMJ Case Rep; 2017 Jan; 2017():. PubMed ID: 28122802
[TBL] [Abstract][Full Text] [Related]
17. Hereditary leiomyomatosis and renal cell cancer: update on clinical and molecular characteristics.
Lehtonen HJ
Fam Cancer; 2011 Jun; 10(2):397-411. PubMed ID: 21404119
[TBL] [Abstract][Full Text] [Related]
18. Complete response of hereditary leiomyomatosis and renal cell cancer (HLRCC)-associated renal cell carcinoma to nivolumab and ipilimumab combination immunotherapy by: a case report.
Iribe Y; Furuya M; Shibata Y; Yasui M; Funahashi M; Ota J; Iwashita H; Nagashima Y; Hasumi H; Hayashi N; Makiyama K; Kondo K; Tanaka R; Yao M; Nakaigawa N
Fam Cancer; 2021 Jan; 20(1):75-80. PubMed ID: 32666341
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemistry for 2-Succinocysteine (2SC) and Fumarate Hydratase (FH) in Cutaneous Leiomyomas May Aid in Identification of Patients With HLRCC (Hereditary Leiomyomatosis and Renal Cell Carcinoma Syndrome).
Buelow B; Cohen J; Nagymanyoki Z; Frizzell N; Joseph NM; McCalmont T; Garg K
Am J Surg Pathol; 2016 Jul; 40(7):982-8. PubMed ID: 26945337
[TBL] [Abstract][Full Text] [Related]
20. Advances in hereditary leiomyomatosis and renal cell carcinoma (HLRCC) research.
Ooi A
Semin Cancer Biol; 2020 Apr; 61():158-166. PubMed ID: 31689495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
